CJC-1295 No DAC
$24.99
CJC-1295 without DAC (Modified GRF 1-29) is a synthetic analog of growth hormone–releasing hormone (GHRH). It has been studied in research settings for its role in growth hormone signaling pathways and endocrine regulatory mechanisms related to pulsatile hormone release patterns.
Usage Disclaimer: Research Use Only. This product is intended strictly for laboratory research and in-vitro studies. It is not for human or animal consumption, medical use, or diagnostic purposes. Any unauthorized use of this product is strictly prohibited.
FDA Compliance: FDA Notice. The statements made regarding these products have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Research Studies
Long-term Safety Profile of Modified GRF Analogs (2015)
Animal model | 6 months | Daily administration
No significant adverse effects on pituitary morphology or function with chronic use, supporting the safety of long-term pulsatile GHRH analog administration.
Comparative Analysis: CJC-1295 vs Native GHRH (2010)
In vitro + Human | Various doses | Receptor binding assays
Found CJC-1295 without DAC had 4x greater receptor affinity than native GHRH and enhanced resistance to enzymatic degradation, explaining its superior efficacy.
Growth Hormone Pulsatility with Mod GRF 1-29 (2008)
Human | 100mcg 3x daily | 30 days | 24 subjects
Showed preservation of natural GH pulsatility patterns when administered 3 times daily, with no evidence of pituitary desensitization over the study period.
Pair your peptide order with bacteriostatic water for proper reconstitution and storage. Adding it now ensures you have everything you need when your order arrives.
Avoid delays and complete your setup in one shipment.
